USPTO Grants Patent For Epinex G1A Rapid Diabetes Monitoring Index Test
Epinex said that the granted patent (US7659107B2) is for the rapid glycated albumin test and instrument, which could redefine the way diabetes is monitored for over 250 million
Telix Pharmaceuticals has officially opened a radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, Australia, to expedite the delivery of new treatments for cancer.